An exclusive Advance DoE Workshop 2024 hosted by Eminence Business Media, concluded with resounding success, inspiring participants with valuable insights to enhance their experimental design and optimization skills.
Key Highlights
Expert Sessions : The masterclass leader was renowned industry expert Mr. Igor Gorsky, Principal Consultant, ValSource delivered insightful sessions covering fundamentals of DoE to advanced techniques in process validation and product design. Other experts like Dr. Aruna Khanolkar, Director – QbD, Cipla, and Dr. Arani Chatterjee, Jt. President, Cadila Pharmaceuticals explored in detail Response Surface Methodologies and Fundamentals of Statistics.
Discussions on recent trends and developments in Quality by Design (QbD) methodologies, and risk-based approaches offered valuable insights into the evolving landscape of pharmaceutical manufacturing and quality management.
Exclusive Shimadzu Facility Tour : All delegates visited Shimadzu's state-of-the-art facility where they witnessed GCMS, LCMS, and Spectrometry innovations and hands-on experience of the latest analytical and molecule separation technology.
Interactive Workshops : Hands-on case studies and group exercises provided participants with practical experience in applying DoE principles to real-world scenarios. These interactive sessions fostered collaborative learning and problem-solving.
Invaluable Networking : The workshop provided an excellent platform for networking and knowledge exchange among industry professionals, academia, and regulatory experts. Participants had the opportunity to engage with peers, share experiences, and build valuable Connections.
Practical Applications : From optimizing processes to maintaining consistency and ensuring product quality, the workshop emphasized practical applications of DoE techniques in various aspects of pharmaceutical production and quality assurance. As we reflect on the success of the Advance DoE Workshop 2024, we look forward to seeing the impact of the knowledge and skills gained by participants in driving innovation, efficiency, and compliance in the pharma industry. With a commitment to continuous learning and improvement, we anticipate even greater achievements in the future.
